IP Library Granted Patent US 8,938,299
Granted Patent B2
US 8,938,299 · App. 13/130,287 · Granted Jan 20, 2015

System for treating sleep disordered breathing

Inventors: Mark A. Christopherson (Shoreview, MN); Quan Ni (Shoreview, MN); Timothy P. Herbert (Maple Grove, MN); John Rondoni (Plymouth, MN)
Assignee: Inspire Medical Systems, Inc.
A61N1/3601A61B5/0803A61B5/0809A61B5/4818
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,938,299
App. No.
13/130,287
Granted
Jan 20, 2015
Kind
B2
Abstract

A system is disclosed for applying a treatment therapy for sleep disordered breathing. The system includes a sensing module configured to sense physiologic conditions and an implantable pulse generator in communication with the sensing module and including an automatic therapy manager. The automatic therapy manager operates in a first state to detect sleep indicative behavior, a second state to detect sleep disordered breathing behavior, and a third state to apply a nerve stimulation signal.

Claims (23)

1. A system of applying a treatment therapy for sleep disordered breathing, comprising:

a sensing module including an array of sensors configured to sense physiologic conditions, the array including at least one of a body activity sensor, a body posture sensor, and a respiration sensor; and

an implantable pulse generator in communication with the sensing module and including an automatic therapy manager configured to operate in:

a first state to detect sleep indicative behavior by sensing physiologic conditions via at least the respective body activity sensor and body posture sensor;

a second state to monitor the sensed physiologic conditions to detect sleep disordered breathing behavior, wherein the therapy manager transitions into the second state when the detected sleep-indicative behavior meets a first criteria; and

a third state to apply a nerve stimulation signal, synchronous with inspiration, to an airway patency-related nerve, wherein the therapy manager transitions into the third state upon detecting, in the second state, sleep disordered breathing behavior exceeding a second criteria,

wherein the automatic therapy manager includes an inverse relationship sampling function configured, in cooperation with the sensing module, to perform sampling of physiologic conditions in the second state at intervals according to an inverse relationship between the amount of patient body activity and the frequency of sampling, such that upon sensing a higher degree of patient body activity that corresponds to a lower likelihood of detecting sleep, performing a lower frequency of sampling physiologic conditions and upon sensing a lower degree of patient body activity corresponding to higher likelihood of detecting sleep, performing a higher frequency of sampling physiologic conditions.

2. The system of claim 1 , wherein the automatic therapy manager includes a suspension function configured, upon detecting the sleep disordered breathing behavior falling below the second criteria, to suspend the third state of operation and maintaining the respective first and second state of operation.

3. The system of claim 1 , wherein the automatic therapy manager includes a bypass function configured, upon detecting a sleep state in the first state of operation, to bypass the second state of operation and immediately implement the third state of operation.

4. A system of applying a treatment therapy for sleep disordered breathing, comprising:

a sensing module including an array of sensors configured to sense physiologic conditions, the array including at least one of a body activity sensor, a body posture sensor, and a respiration sensor; and

an implantable pulse generator in communication with the sensing module and including an automatic therapy manager configured to operate in:

a first state to detect sleep indicative behavior by sensing physiologic conditions via at least the respective body activity sensor and body posture sensor;

a second state to monitor the sensed physiologic conditions to detect sleep disordered breathing behavior, wherein the therapy manager transitions into the second state when the detected sleep-indicative behavior meets a first criteria; and

a third state to apply a nerve stimulation signal, synchronous with inspiration, to an airway patency-related nerve, wherein the therapy manager transitions into the third state upon detecting, in the second state, sleep disordered breathing behavior exceeding a second criteria, wherein the detection of sleep disordered breathing behavior exceeding the second criteria includes detection of an occurrence of at least one obstructive sleep apnea event,

wherein the automatic therapy manager includes a periodic suspension function configured to:

periodically suspend the third state of operation while maintaining the respective first and second state of operation during the periodic suspensions;

detect whether the monitored sleep disordered breathing behavior exceeds the second criteria; and

implement at least one of maintaining suspension of the third state of operation if the monitored sleep disordered breathing behavior fails to meet the second criteria or resuming the third state of operation if the monitored sleep disordered breathing behavior meets or exceeds the second criteria,

wherein the periodic suspension function is configured to periodically suspend the third state of operation at a frequency and for a predetermined suspension time period,

wherein the frequency of suspending is inversely proportional to a severity score of the sleep disordered breathing behavior, such that upon a relatively higher severity score, a lower frequency of suspending occurs and upon a relatively lower severity score, a higher frequency of suspending occurs, wherein the severity score is based at least one of a quantity, duration, and intensity of obstructive sleep apneas within a given time period.

5. The system of claim 4 , wherein the periodic suspension function is configured to automatically forego suspension of the third state of operation during an initial sleep stage of a daily sleep period.

6. The system of claim 4 , wherein the periodic suspension function is configured to automatically forego suspension of the third state of operation for a daily sleep period upon detecting that the monitored sleep disordered breathing behavior substantially exceeds the second criteria.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 26, 2015
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INSPIRE MEDICAL SYSTEMS, INC.
Reel/Frame 036431/0126 →
SECURITY AGREEMENT Recorded Nov 16, 2012
From: INSPIRE MEDICAL SYSTEMS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 029311/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2011
From: CHRISTOPHERSON, MARK A.; NI, QUAN; HERBERT, TIMOTHY P.; RONDONI, JOHN
To: INSPIRE MEDICAL SYSTEMS, INC.
Reel/Frame 026495/0600 →
Continuity (2)
Provisional Application 61116149 · Nov 19, 2008
Related Publication 20110264164A1 · Oct 27, 2011